Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib

By                    

Oncology Letters, Vol. 3, Iss. 3, 2012-01 ,pp. : 713-717

Spandidos Publications

Access to resources Recommend Favorite

Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung

By Rahman Shakibur   Kondo Nobuyuki   Yoneda Kazue   Takuwa Teruhisa   Hashimoto Masaki   Orui Hayato   Okumura Yoshitomo   Tanaka Fumihiro   Kumamoto Kanako   Mostafa Mohammad   Chowdhury Golam   Haque Akramul   Hasegawa Seiki  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 45-49

Springer Publishing Company

Access to resources Recommend Favorite

Biological Characteristics and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Efficacy of EGFR Mutation and its Subtypes in Lung Adenocarcinoma

By Lu Rong-li   Hu Cheng-Ping   Yang Hua-ping   Li Yuan-yuan   Gu Qi-hua   Wu Lielin  

Pathology & Oncology Research, Vol. 20, Iss. 2, 2014-04 ,pp. : 445-451

Springer Publishing Company

Access to resources Recommend Favorite

Investigation of the epidermal growth factor receptor mutation rate in nonsmall cell lung cancer patients and the analysis of associated risk factors using logistic regression

By              

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 813-818

Spandidos Publications

Access to resources Recommend Favorite

Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells

By Hsu Andrew   Zhang Wenliang   Lee Jen-Fu   An Jin   Ekambaram Prasanna   Liu Jingjing   Honn Kenneth V.   Klinge Carolyn M.   Lee Menq-Jer  

International Journal of Oncology, Vol. 40, Iss. 5, 2012-05 ,pp. : 1619-1626

Spandidos Publications

Access to resources Recommend Favorite